Literature DB >> 22475803

Positive end-expiratory pressure following coronary artery bypass grafting.

D A Dongelmans1, S N Hemmes, A C Kudoga, D P Veelo, J M Binnekade, M J Schultz.   

Abstract

BACKGROUND: Cardiac surgery-related pulmonary complications include alterations in lung mechanics and anomalies in gas exchange. Higher levels of positive end-expiratory pressure (PEEP) have been suggested to benefit cardiac surgical patients. We compared respiratory compliance, arterial oxygenation and time till tracheal extubation in 2 cohorts of patients weaned from mechanical ventilation with different levels of PEEP after elective and uncomplicated coronary artery bypass grafting (CABG). We hypothesized that higher PEEP levels improve pulmonary compliance and gas exchange in the first hours of weaning from mechanical ventilation, but not to shorten time till tracheal extubation.
METHODS: Secondary retrospective analysis of 2 randomized controlled trials: in the first trial patients were weaned with PEEP levels of 10 cmH2O for the first 4 hours followed by PEEP levels of 5 cmH2O until tracheal extubation (high PEEP, HP); and the second trial patients were weaned with PEEP levels of 5 cmH2O during the entire weaning phase (low PEEP, LP). The primary endpoint was pulmonary compliance. Secondary endpoints included arterial oxygenation, duration of mechanical ventilation and postoperative pulmonary complications.
RESULTS: The analysis included 121 patients; 60 HP patients and 61 LP patients. Baseline characteristics were similar. Compared to LP patients, HP patients had a better pulmonary compliance, 47.2±14.1 versus 42.7±10.2 ml/cmH2O (P<0.05), and higher levels of PaO2, 18.5±6.6 (138.75±49.5) versus 16.7±5.4 (125.25±40.5) kPa (mmHg) (P<0.05). Patients in the HP group were less frequent in need of supplementary oxygen after ICU discharge. These differences remained present during the entire weaning phase, even after reduction of PEEP. However, HP patients had a longer time till tracheal extubation, 16.9±6.1 versus 10.5±5.0 hours (P<0.001). HP patients had longer durations of postoperative infusion of propofol, 4.9 (2.6-7.4) versus 3.5 (1.8-5.8) hours (P<0.05). There were no differences in use of inotropes. Cumulative fluid balances were slightly higher in HP patients.
CONCLUSION: Use of higher PEEP levels after elective uncomplicated CABG improves pulmonary compliance and oxygenation but seems to be associated with a delay in tracheal extubation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22475803

Source DB:  PubMed          Journal:  Minerva Anestesiol        ISSN: 0375-9393            Impact factor:   3.051


  11 in total

Review 1.  Acute respiratory distress syndrome after cardiac surgery.

Authors:  Lisa Q Rong; Antonino Di Franco; Mario Gaudino
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

Review 2.  State of the evidence: mechanical ventilation with PEEP in patients with cardiogenic shock.

Authors:  Jonathan Wiesen; Moshe Ornstein; Adriano R Tonelli; Venu Menon; Rendell W Ashton
Journal:  Heart       Date:  2013-03-28       Impact factor: 5.994

3.  Relationship between pre-extubation positive end-expiratory pressure and oxygenation after coronary artery bypass grafting.

Authors:  Reijane Oliveira Lima; Daniel Lago Borges; Marina de Albuquerque Gonçalves Costa; Thiago Eduardo Pereira Baldez; Mayara Gabrielle Barbosa e Silva; Felipe André Silva Sousa; Milena de Oliveira Soares; Jivago Gentil Moreira Pinto
Journal:  Rev Bras Cir Cardiovasc       Date:  2015 Jul-Aug

4.  The effect of postoperative positive end-expiratory pressure on postoperative bleeding after off-pump coronary artery bypass grafting.

Authors:  Yahya Yildiz; Ece Salihoglu; Sezai Celik; Murat Ugurlucan; Ilker Murat Caglar; Fatma Nihan Turhan-Caglar; Omer Isik
Journal:  Arch Med Sci       Date:  2014-10-23       Impact factor: 3.318

5.  Associations between positive end-expiratory pressure and outcome of patients without ARDS at onset of ventilation: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Ary Serpa Neto; Roberto Rabello Filho; Thomas Cherpanath; Rogier Determann; Dave A Dongelmans; Frederique Paulus; Pieter Roel Tuinman; Paolo Pelosi; Marcelo Gama de Abreu; Marcus J Schultz
Journal:  Ann Intensive Care       Date:  2016-11-03       Impact factor: 6.925

6.  Early Open-Lung Ventilation Improves Clinical Outcomes in Patients with Left Cardiac Dysfunction Undergoing Off-Pump Coronary Artery Bypass: a Randomized Controlled Trial.

Authors:  Douglas W Bolzan; Walter José Gomes; Isadora S Rocco; Marcela Viceconte; Mara L S Nasrala; Hayanne O Pauletti; Rita Simone L Moreira; Nelson A Hossne; Ross Arena; Solange Guizilini
Journal:  Braz J Cardiovasc Surg       Date:  2016 Sep-Oct

7.  The prophylactic effect of different levels of positive endexpiratory pressure on the incidence rate of atelectasis after cardiac surgery: A Randomized Controlled Trial.

Authors:  Mostafa Setak-Berenjestanaki; Masoumeh Bagheri-Nesami; Afshin Gholipour Baradari; Seyed Nouraddin Mousavinasab; Rahman Ghaffari; Manijeh Darbeheshti
Journal:  Med J Islam Repub Iran       Date:  2018-03-10

8.  Positive expiratory pressure improves oxygenation in healthy subjects exposed to hypoxia.

Authors:  Hugo Nespoulet; Thomas Rupp; Damien Bachasson; Renaud Tamisier; Bernard Wuyam; Patrick Lévy; Samuel Verges
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

9.  Hemodynamics and tissue oxygenation effects after increased in positive end-expiratory pressure in coronary artery bypass surgery.

Authors:  Vanessa Marques Ferreira Méndez; Mayron F Oliveira; Adriana do Nascimento Baião; Patrícia Andrade Xavier; Carlos Gun; Priscila A Sperandio; Iracema I K Umeda
Journal:  Arch Physiother       Date:  2017-01-11

10.  Intra-aortic balloon pump combined with mechanical ventilation for treating patients aged > 60 years in cardiogenic shock: Retrospective analysis.

Authors:  Hongwei Liu; Xueping Wu; Xiaoning Zhao; Ping Zhu; Lina Han
Journal:  J Int Med Res       Date:  2016-03-28       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.